US Stock MarketDetailed Quotes
ASMB Assembly Biosciences
- 15.160
- -0.220-1.43%
Close Dec 27 16:00 ET
96.36MMarket Cap-2.20P/E (TTM)
15.562High14.860Low30.91KVolume15.380Open15.380Pre Close469.08KTurnover1.06%Turnover RatioLossP/E (Static)6.36MShares19.93052wk High3.71P/B44.26MFloat Cap9.12152wk Low--Dividend TTM2.92MShs Float1260.000Historical High--Div YieldTTM4.56%Amplitude7.692Historical Low15.176Avg Price1Lot Size
Assembly Biosciences Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -10.08%-15.24M | -25.49%-17.1M | 21.62%-18.36M | 126.93%22.74M | 482.50%73.65M | 30.14%-13.85M | 23.80%-13.63M | 14.81%-23.43M | 9.56%-84.46M | 0.56%-19.25M |
| Net income from continuing operations | 33.34%-9.61M | 34.00%-11.15M | 52.10%-9.08M | 34.23%-61.23M | 51.05%-10.96M | 37.70%-14.42M | 30.93%-16.9M | 17.93%-18.95M | 28.31%-93.09M | 62.83%-22.4M |
| Operating gains losses | ---- | ---- | ---- | --139K | ---- | ---- | ---- | ---- | ---- | ---- |
| Depreciation and amortization | -71.55%33K | -74.60%32K | -74.19%32K | -9.64%450K | -32.26%84K | -13.43%116K | 5.00%126K | 3.33%124K | 6.87%498K | 3.33%124K |
| Other non cash items | -56.99%351K | -58.55%354K | -58.01%359K | 0.06%3.51M | 14.05%982K | -5.12%816K | -4.15%854K | -4.26%855K | -8.72%3.51M | -4.33%861K |
| Change In working capital | -405.16%-5.97M | -590.06%-6.21M | -26.42%-9.15M | 3,697.60%76.34M | 37,510.81%83.5M | -256.97%-1.18M | -67.67%1.27M | -3.19%-7.24M | 81.39%-2.12M | -86.43%222K |
| -Change in receivables | --0 | -88.53%43K | --0 | 248.19%901K | -114.24%-43K | 147.30%342K | 37,400.00%375K | 220.74%227K | -168.01%-608K | -30.25%302K |
| -Change in prepaid assets | 1.57%453K | -79.22%437K | 59.20%-652K | -31.02%916K | 95.22%-35K | -76.54%446K | 1,129.82%2.1M | -13,216.67%-1.6M | 19.75%1.33M | -190.71%-732K |
| -Change in payables and accrued expense | 188.57%767K | 805.76%2.08M | 59.08%-2.25M | -41,814.29%-5.84M | -2.82%827K | -290.75%-866K | -107.14%-295K | -1.57%-5.51M | 100.17%14K | -23.13%851K |
| -Change in other current assets | --0 | --0 | --0 | -29.12%577K | -66.85%240K | -1,100.00%-220K | -99.63%2K | 217.58%555K | -82.64%814K | 230.59%724K |
| -Change in other current liabilities | 60.86%-346K | 74.07%-238K | 49.56%-463K | -2.83%-3.77M | -14.19%-1.05M | 1.89%-884K | 0.54%-918K | 0.54%-918K | 3.06%-3.67M | 0.75%-923K |
| -Change in other working capital | ---6.85M | ---8.53M | ---5.79M | --83.56M | ---- | ---- | ---- | ---- | ---- | ---- |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -10.08%-15.24M | -25.49%-17.1M | 21.62%-18.36M | 126.93%22.74M | 482.50%73.65M | 30.14%-13.85M | 23.80%-13.63M | 14.81%-23.43M | 9.56%-84.46M | 0.56%-19.25M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 29.70%24.49M | 161.05%5.11M | 72.72%17.27M | -176.28%-69.14M | -641.32%-89.65M | -39.93%18.88M | -187.16%-8.37M | -69.74%10M | 241.84%90.64M | 295.21%16.56M |
| Net PPE purchase and sale | --0 | 70.83%-14K | ---14K | -126.47%-231K | ---47K | -33.33%-136K | ---48K | --0 | 95.44%-102K | --0 |
| Net business purchase and sale | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | 0.00%1.5M | ---- |
| Net investment purchase and sale | 28.77%24.49M | 161.57%5.12M | 72.86%17.29M | -177.21%-68.91M | -694.92%-89.61M | -39.69%19.02M | -186.66%-8.32M | -69.74%10M | 227.45%89.24M | 251.13%15.06M |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | 29.70%24.49M | 161.05%5.11M | 72.72%17.27M | -176.28%-69.14M | -641.32%-89.65M | -39.93%18.88M | -187.16%-8.37M | -69.74%10M | 241.84%90.64M | 295.21%16.56M |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 0 | 9,194.03%12.45M | 0 | 2,150.49%13.82M | 2,003.43%9.19M | 0 | -24.29%134K | 4.49M | -98.84%614K | -83.89%437K |
| Net common stock issuance | --0 | 22,853.70%12.4M | --0 | 4,112.00%13.69M | 2,713.23%9.14M | --0 | --54K | --4.49M | -99.38%325K | -87.50%325K |
| Proceeds from stock option exercised by employees | --0 | ---- | ---- | -55.36%129K | -56.25%49K | --0 | ---- | ---- | 12.02%289K | -1.75%112K |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | --0 | 9,194.03%12.45M | --0 | 2,150.49%13.82M | 2,003.43%9.19M | --0 | -24.29%134K | --4.49M | -98.84%614K | -83.89%437K |
| Net cash flow | ||||||||||
| Beginning cash position | -11.17%19.21M | -56.88%18.75M | -62.15%19.84M | 14.88%52.42M | -51.24%26.66M | -49.79%21.62M | -15.03%43.48M | 14.88%52.42M | -23.24%45.63M | -22.73%54.67M |
| Current changes in cash | 83.67%9.24M | 102.10%459K | 87.78%-1.09M | -579.71%-32.58M | -202.22%-6.82M | -56.65%5.03M | -169.50%-21.86M | -261.10%-8.94M | 149.15%6.79M | 91.03%-2.26M |
| End cash Position | 6.74%28.45M | -11.17%19.21M | -56.88%18.75M | -62.15%19.84M | -62.15%19.84M | -51.24%26.66M | -49.79%21.62M | -15.03%43.48M | 14.88%52.42M | 14.88%52.42M |
| Free cash flow | -9.01%-15.24M | -25.15%-17.12M | 21.56%-18.38M | 126.59%22.49M | 482.13%73.58M | 29.81%-13.98M | 23.53%-13.68M | 14.81%-23.43M | 12.36%-84.57M | 0.65%-19.25M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- |
Heat List
US
Overall
Symbol
Price
% Chg
No Data